Latest filing published 10 May 2017 for China Biologic Products, Inc., €679k.
All filings by Zhijing CBPO Liu on record concern China Biologic Products, Inc. Over a trading history stretching from 16 August 2013 to 9 May 2017, the count stands at 19 filings.
The open-market record consists of 9 sales worth €2.5M, with no purchase. Other entries cover 6 share grants and 4 option exercises. 2017 to date brings no purchases and 2 sales.
Most recently, on 10 May 2017, the filings show an option exercise worth €57k in China Biologic Products, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations